The relation between the blood glucose level and the FDG uptake of tissues at normal PET examinations

EJNMMI Research

Volumn 3, Issue 1, 2013, Pages 1-5

  Lindholm, Henry ^a   Brolin, Fredrik ^a   Jonsson, Cathrine ^a   Jacobsson, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

FDG PET; Hyperglycaemia; Normal tissue; SUV; Tracer distribution

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN;

ADOLESCENT; ADULT; AGED; ANALYTICAL PARAMETERS; ANATOMICAL VARIATION; ARTICLE; BLOOD; BONE MARROW; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GRANULOPOIESIS; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; IMAGE ANALYSIS; LIVER; LUNG; MAJOR CLINICAL STUDY; MALE; MUSCLE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIOTHERAPY; RETROSPECTIVE STUDY; SCHOOL CHILD; SPLEEN;

EID: 84881235404     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-3-50     Document Type: Article

References (21)

1. Wahl RL, Cody RL, Hutchins GD, Mudgett EE: Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1991, 179:765-770.
2. Wahl RL, Henry CA, Ethier SP: Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 1992, 183:643-647.
3. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H: Influence of the blood glucose concentration of FDG uptake in cancer-a PET study. J Nucl Med 1993, 34:1-6.
4. Langen K-J, Braun U, Rota Kops E, Herzog H, Kuwert T, Nebeling B, Feinendegen LE: The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 1993, 34:355-359.
5. 18F]Fluorodeoxyglucose uptake in tumors: kinetic vs. steady-state methods with reference to plasma insulin. J Comput Assist Tomogr 1993, 17:115-123.
6. 18F-labelled deoxyglucose: method and first results. Nucl Med Commun 1993, 14:596-601.
7. Bares R, Klever P, Hauptmann S, Hellwig D, Fass J, Cremeruis U, Schumpelick V, Mittermayer C, Büll U: F-18 fluorodexyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994, 192:79-86.
8. Boellaard R, O'Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, Oyen WJ, Kotzerke J, Hoekstra OS, Pruim J, Marsden PK, Tatsch K, Hoekstra CJ, Visser EP, Arends B, Verzijlbergen FJ, Zijlstra JM, Comans EF, Lammertsma AA, Paans AM, Willemsen AT, Beyer T, Bockisch A, Schaefer-Prokop C, Delbeke D, Baum RP, Chiti A, Krause BJ: FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010, 37:181-200.
9. 18F-FDG PET/CT 1.0. J Nucl Med 2006, 47:885-895.
10. 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A comparative analysis. J Nucl Med 2010, 51:1015-1020.
11. Lindholm H, Johansson O, Jonsson C, Jacobsson H: The distribution of FDG at PET examinations constitutes a relative mechanism: significant effects at activity quantification in patients with a high muscular uptake. Eur J Nucl Med Mol Imaging 2012, 39:1685-1690.
12. Colton T: Statistics in Medicine. Boston: Little, Brown and Co.; 1974.
13. Khirwadkar H, Rees J, Jayaprakasam S, Fielding P: Does high serum glucose really predict poor image quality in FDG PET/CT? [abstract]. Eur J Nucl Med Mol Imaging 2012, 38:s388-s389.
14. Hara T, Higashi T, Nakamoto Y, Suga T, Saga T, Ishimori T, Ishizu K, Kawashima H, Kawase S, Matsumoto K, Togashi K: Significance of chronic marked hyperglycemia on FDG-PET: is it really problematic for clinical oncologic imaging? Ann Nucl Med 2009, 23:657-669.
15. 18F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med 1985, 10:341-345.
16. Beanlands RSB, Thorn S, Dasilva J, Ruddy TD, Maddahi J: Myocardial viability. In Principle and Practice of PET and PET/CT. 2nd edition. Edited by Wahl RL. Philadelphia: Lippincott Williams & Wilkins; 2009:565-588.
17. Crippa F, Gavazzi C, Bozzetti F, Chiesa C, Pascali C, Bogni A, De Sanctis V, Decise D, Schiavini M, Cucchetti G, Bombardieri E: The influence of blood glucose levels on [18F]fluorodeoxyglucose (FDG) uptake in cancers: a PET study in liver metastases from colorectal carcinomas. Tumori 1997, 83:748-752.
18. Diedrichs CG, Staib L, Glatting G, Beger HG, Reske SN: FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med 1998, 39:1030-1033.
19. Torizuka T, Zasadny KR, Wahl RL: Diabetes decreases FDG accumulation in primary lung cancer. Clin Positron Imaging 1999, 2:281-287.
20. Gould GW, Holman GD: The glucose transporter family: structure, function and tissue-specific expression. Biochem J 1993, 295:329-341.
21. Ismail-Beigi F: Metabolic regulation of glucose transport. J Membr Biol 1993, 135:1-10.